Create a narrative

scPharmaceuticals Community

NasdaqGS:SCPH Community

1 Narratives written by author
0 Comments on narratives written by author
11 Fair Values set on narratives written by author

Create a narrative

scPharmaceuticals

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

Medicare Redesign And At-Home Care Will Open New Markets

Key Takeaways Adoption of FUROSCIX is accelerating due to improved patient access, expanded indications, and positive trends in home-based care, enhancing long-term revenue prospects. Enhanced commercial strategies and upcoming product innovation are boosting prescription rates, market penetration, and margins, driving sustained business growth.

US$15.60

FV

67.1% undervalued

72.24%

Revenue growth p.a.

0

0

5

5 days ago